What Forian does

Forian Inc. is a US-based healthcare data and analytics company that operates a cloud-native, HIPAA- and SOC-2-compliant platform anchored by its proprietary CHRONOS hybrid data ecosystem, which integrates open and closed medical claims, electronic health records (EHR), and social determinants of health (SDoH) data covering 370M+ patients including 100M+ hybrid patients with longitudinal follow-up. Layered on top of the Data Factory foundation are commercial analytics modules targeting life sciences (HCP targeting, campaign activation, audience profiling, performance measurement), a Real World Evidence (RWE) service line for clinical and economic evidence generation, the Opsis provider intelligence platform covering 75% of US patients and 98% of US providers, and the Chartis healthcare network mapping product spanning 9,000+ hospitals, 200,000+ organizations, and 2.1M+ practitioners. In October 2024, Forian acquired Kyber Data Science from Cowen Inc., adding real-time, ML-driven claims-based revenue intelligence for Wall Street healthcare investors and establishing a financial services vertical alongside its legacy life sciences, payer, and provider segments.

Revenue is generated through a mix of subscription-based SaaS analytics access to CHRONOS, Opsis, Chartis, and Kyber, licensing of proprietary de-identified healthcare datasets, and professional services for custom Real World Evidence studies; pricing is quote-based and not publicly disclosed, reflecting a consultative enterprise sales motion. The company sells via direct enterprise sales with dedicated engagement pathways for commercial analytics, data management, outcomes research, and RWE studies, supported by content marketing (peer-reviewed publications, blog, white papers) and presence at healthcare conferences such as ISPOR. The company's go-to-market emphasizes HIPAA-compliant, audit-ready infrastructure as a procurement differentiator in regulated buyer environments.

Forian was publicly traded on Nasdaq (FORA) from 2021 until May 2026, when it completed a $2.17-per-share going-private transaction with a consortium led by CEO and Executive Chair Max Wygod, valuing the company at approximately $67.7M; in March 2026, ahead of closing, Forian disclosed a material weakness in internal control over financial reporting related to revenue recognition under ASC 606. As of the closing, Forian employs 51–100 people and operates from its Newtown, Pennsylvania headquarters.

Name

Forian

Legal name

Forian Inc.

Website

https://forian.com

Company type

Public

Founded year

2021

Operating status

Acquired

Headcount range

51–100 employees

Short description

Forian is a Newtown, PA-based healthcare data and analytics SaaS provider whose CHRONOS platform integrates open and closed claims, EHR, and social determinants of health data at national scale, serving life sciences, payer, provider, and (via Kyber) financial services customers with commercial analytics, real-world evidence, and claims-based revenue intelligence.

Ownership category

akta.pro rank

Product category

Healthcare Data Analytics

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Custom Computer Programming Services (541511)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)

akta.pro primary industry

Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF)

akta.pro secondary industries

Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB), FHIR/HL7 Data Repositories & Canonical Data Models (HLACAIAI), Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Healthcare data analytics
• Real world evidence
• Claims data analytics
• Healthcare SaaS
• Predictive analytics

Headquarters

HQ city

Newtown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Healthcare Data Analytics Solutions: Software-as-a-service platform providing data analytics, real-world evidence generation, and predictive analytics to healthcare and life sciences companies. Solutions are sold as integrated platforms with recurring subscription or contract pricing.
2. Kyber Data Science - Revenue Intelligence: Real-time claims intelligence and predictive revenue insights sold to healthcare investors and financial services clients. Provides early revenue forecasting, backtesting, and ML forecasting models.
3. Data Licensing: Licensing of proprietary de-identified healthcare data assets to life sciences companies, payers, and providers for research, commercial targeting, and market assessment purposes.
4. Real World Evidence Studies: Full-service consulting and custom research engagements generating evidence about product economic and clinical value, safety, efficacy, and market performance.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Forian provides a suite of SaaS solutions, proprietary healthcare data, and analytics that enable life sciences companies, healthcare payers, providers, and financial services firms to conduct commercial analytics, real-world evidence generation, provider network mapping, and predictive revenue intelligence. The offering is anchored by the CHRONOS hybrid data ecosystem, which combines open and closed medical claims, electronic health records, and social determinants of health data for 370M+ patients, and is delivered through cloud-based platforms including Data Factory, Kyber Data Science, Chartis, and Opsis.

Product overview

Forian offers a platform-plus-modules architecture anchored by CHRONOS, its proprietary hybrid data ecosystem that integrates open and closed claims, EHR, and social determinants of health data. The portfolio includes Kyber Data Science (acquired October 2024) for real-time claims intelligence targeting financial services clients, Chartis for healthcare network mapping, Opsis for commercial targeting, and Real World Evidence services. The Data Factory serves as the underlying technology platform providing data ingestion, processing, governance, and analytics capabilities. Products support life sciences, healthcare payers, providers, and financial services customers with measurable evidence-based improvements in performance.

Differentiator

Problem solved

Functional benefit

Brands

• CHRONOS: Forian's hybrid data ecosystem combining open and closed claims, electronic health records, and social determinants of health data into a single integrated model.
• Chartis
• Kyber Data Science
• Opsis
• Real World Evidence (RWE)

Products and services

• CHRONOS Proprietary hybrid healthcare data ecosystem that integrates open and closed medical claims, electronic health records (EHR), and social determinants of health (SDoH) data into a single, integrated model covering 370M+ patients and 100M+ hybrid patients with approximately 4 years of longitudinal follow-up. Used by life sciences companies for real-world evidence generation and commercial analytics.
• Data Factory Cloud-based foundational platform that transforms raw, unstructured, disparate healthcare data into a cleansed, connected, and normalized data lake using ML-powered ETL, SOC-2 and HIPAA-compliant governance, and proprietary taxonomies. Supports downstream analytics products including CHRONOS, Chartis, and Opsis.
• Chartis Healthcare network mapping solution using a proprietary scoring algorithm to reveal meaningful connections between practitioners and organizations. Classifies 9,000+ hospitals, 200,000+ healthcare organizations, and 2.1M+ practitioners with verified contact information for use by commercial targeting teams.
• Opsis Provider targeting and market analysis platform that empowers commercial, brand, and marketing teams to understand markets and evaluate provider landscapes for key indications or treatments. Covers 75% of patients and 98% of providers in the U.S.
• Kyber Data Science Real-time, revenue-focused claims intelligence platform that uses ML forecasting models, KPI dashboards, and clean claims data to help healthcare investors predict revenue and track performance across hundreds of products and tickers. Targets Wall Street firms, hedge funds, and investment banks.
• Real World Evidence Real-world evidence generation service combining multiple RWD sources (payer, provider, clinical, and SDoH data) in a HIPAA-compliant manner, with full-service consulting and custom linkages to assess product safety, efficacy, and economic value outside of controlled clinical trials.

Quantifiable outcome

• 370M+ patients covered with 100M+ hybrid patients in the CHRONOS data ecosystem
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/forianinc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Forian